NCT03514810View on ClinicalTrials.gov

Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

September 10, 2017

Study Completion Date

December 31, 2017

Conditions
Major Depressive Disorder
Interventions
COMBINATION_PRODUCT

Combined Sertraline & Ketoprofen

The first group of patients has administered sertralin (50mg)+placebo. The second group has administered sertralin (50mg)+ketoprofen (100mg) (Sertraline \& Ketoprofen) daily.

OTHER

Interleukins in MDD after treatment

Some interleukine levels were estimated in the first group of patients (administered sertralin,50mg+ketoprofen,100mg) and compared with their level in the second group (administered sertralin (50mg)+placebo).

All Listed Sponsors
lead

Kufa University

OTHER

NCT03514810 - Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder | Biotech Hunter | Biotech Hunter